Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen.
Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy.
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.
Hesketh PJ. Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists. Support Care Cancer. 1994 Sep; 2(5):286-92.
View in:
PubMed
subject areas
Antiemetics
Antineoplastic Agents
Cisplatin
Dexamethasone
Humans
Metoclopramide
Nausea
Neoplasms
Prospective Studies
Serotonin
Serotonin Antagonists
Vomiting
authors with profiles
Paul Joseph Hesketh MD